Ginsenoside Rb1 inhibits neuronal apoptosis and damage, enhances spinal aquaporin 4 expression and improves neurological deficits in rats with spinal cord ischemia‑reperfusion injury

Huang,Fei; Li,Ya‑Nan; Yin,Fei; Wu,Yun‑Tao; Zhao,Dong‑Xu; Li,Ye; Zhang,Yun‑Feng; Zhu,Qing‑San

doi:10.3892/mmr.2015.3162

Ginsenoside Rb1 inhibits neuronal apoptosis and damage, enhances spinal aquaporin 4 expression and improves neurological deficits in rats with spinal cord ischemia‑reperfusion injury

Authors:
- Fei Huang
- Ya‑Nan Li
- Fei Yin
- Yun‑Tao Wu
- Dong‑Xu Zhao
- Ye Li
- Yun‑Feng Zhang
- Qing‑San Zhu
View Affiliations

Affiliations: Department of Orthopedics, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Pediatrics, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: January 8, 2015 https://doi.org/10.3892/mmr.2015.3162
Pages: 3565-3572

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ginsenoside Rb1 is a potential therapeutic agent for the treatment of spinal cord ischemia‑reperfusion injury (SCII), although it has not yet been investigated in depth. The aim of the present study was to investigate the effects of ginsenoside Rb1 treatment on SCII and aquaporin‑4 (AQP4) expression in the rat spinal cord. Experimental animals were subjected to one of four conditions, including the blank control condition, sham procedure, spinal cord ischemia‑reperfusion induced by abdominal aortic occlusion or spinal cord ischemia‑reperfusion followed by ginsenoside Rb1 treatment. Locomotor activity was evaluated using the Basso Beattie Bresnahan scale. Spinal cord damage was assessed with hematoxylin and eosin and Nissl staining and the apoptotic rate was measured using terminal deoxynucleotidyl transferase dUTP nick end labeling. AQP4 expression was assessed by immunohistochemical analysis, western blotting and reverse transcription‑quantitative polymerase chain reaction. Abdominal aortic occlusion resulted in the reduced expression of AQP4 in the spinal cord, which gradually recovered over time. Furthermore, ginsenoside Rb1 treatment significantly attenuated this decrease and protected the integrity of and reduced the apoptotic rate in spinal cord neurons. Treatment with ginsenoside Rb1 attenuated the initial downregulation and advanced the recovery of AQP4 expression levels, suggesting a possible mechanism for the therapeutic effects on SCII.

View Figures

View References

1	Wang JY, Shen J, Gao Q, et al: Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke. 39:983–990. 2008. View Article : Google Scholar : PubMed/NCBI
2	Omura A and Okita Y: Surgical treatment of thoracoabdominal aortic aneurysm. Kyobu Geka. 65:67–79. 2012.PubMed/NCBI
3	Xing B, Chen H, Zhang M, et al: Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke. 39:2362–2369. 2008. View Article : Google Scholar : PubMed/NCBI
4	Park ES, Gao X, Chung JM and Chung K: Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons. Neurosci Lett. 391:108–111. 2006. View Article : Google Scholar
5	Varija D, Kumar KP, Reddy KP and Reddy VK: Prolonged constriction of sciatic nerve affecting oxidative stressors & antioxidant enzymes in rat. Indian J Med Res. 129:587–592. 2009.PubMed/NCBI
6	Ning N, Dang X, Bai C, Zhang C and Wang K: Panax notoginsenoside produces neuroprotective effects in rat model of acute spinal cord ischemia-reperfusion injury. J Ethnopharmacol. 139:504–512. 2012. View Article : Google Scholar
7	Oshio K, Binder DK, Yang B, Schecter S, Verkman AS and Manley GT: Expression of aquaporin water channels in mouse spinal cord. Neuroscience. 127:685–693. 2004. View Article : Google Scholar : PubMed/NCBI
8	Rash JE, Yasumura T, Hudson CS, Agre P and Nielsen S: Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci USA. 95:11981–11986. 1998. View Article : Google Scholar : PubMed/NCBI
9	Nesic O, Lee J, Ye Z, et al: Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience. 143:779–792. 2006. View Article : Google Scholar : PubMed/NCBI
10	Saadoun S, Bell BA, Verkman AS and Papadopoulos MC: Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice. Brain. 131:1087–1098. 2008. View Article : Google Scholar : PubMed/NCBI
11	Hinson SR, McKeon A and Lennon VA: Neurological autoimmunity targeting aquaporin-4. Neuroscience. 168:1009–1018. 2010. View Article : Google Scholar
12	Nicaise C, Soyfoo MS, Authelet M, et al: Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken). 292:207–213. 2009. View Article : Google Scholar
13	Radad K, Gille G, Liu L and Rausch WD: Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci. 100:175–186. 2006. View Article : Google Scholar : PubMed/NCBI
14	Zhao J, Su C, Yang C, et al: Determination of ginsenosides Rb1, Rb2 and Rb3 in rat plasma by a rapid and sensitive liquid chromatography tandem mass spectrometry method: Application in a pharmacokinetic study. J Pharm Biomed Anal. 64–65:94–97. 2012. View Article : Google Scholar
15	Wu L, Jin Y, Yin C and Bai L: Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides. J Ind Microbiol Biotechnol. 39:521–527. 2012. View Article : Google Scholar : PubMed/NCBI
16	Lee JG, Baek SH, Lee YY, Park SY and Park JH: Anti-complementary ginsenosides isolated from processed ginseng. Biol Pharm Bull. 34:898–900. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kwok HH, Guo GL, Lau JK, et al: Stereoisomers ginsenosides-20(S)-Rg₃ and -20(R)-Rg₃ differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma. Biochem Pharmacol. 83:893–902. 2012. View Article : Google Scholar : PubMed/NCBI
18	Yuan HD, Kim do Y, Quan HY, Kim SJ, Jung MS and Chung SH: Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells. Chem Biol Interact. 195:35–42. 2012. View Article : Google Scholar
19	Ha SE, Shin DH, Kim HD, et al: Effects of ginsenoside Rg2 on the ultraviolet B-induced DNA damage responses in HaCaT cells. Naunyn Schmiedebergs Arch Pharmacol. 382:89–101. 2010. View Article : Google Scholar : PubMed/NCBI
20	Jiang JW, Chen XM, Chen XH and Zheng SS: Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol. 17:3605–3613. 2011. View Article : Google Scholar : PubMed/NCBI
21	Poon PY, Kwok HH, Yue PY, et al: Cytoprotective effect of 20S-Rg3 on benzo[a]pyrene-induced DNA damage. Drug Metab Dispos. 40:120–129. 2012. View Article : Google Scholar
22	Lee KT, Jung TW, Lee HJ, Kim SG, Shin YS and Whang WK: The antidiabetic effect of ginsenoside Rb2 via activation of AMPK. Arch Pharm Res. 34:1201–1208. 2011. View Article : Google Scholar : PubMed/NCBI
23	Quan LH, Min JW, Sathiyamoorthy S, Yang DU, Kim YJ and Yang DC: Biotransformation of ginsenosides Re and Rg1 into ginsenosides Rg2 and Rh1 by recombinant β-glucosidase. Biotechnol Lett. 34:913–917. 2012. View Article : Google Scholar : PubMed/NCBI
24	Cheng B, Li J, Du J, Lv X, Weng L and Ling C: Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-κB and MAPKs pathways. Food Chem Toxicol. 50:1610–1615. 2012. View Article : Google Scholar : PubMed/NCBI
25	Tan S, Zhou F, Yu Z, et al: Study on characteristics of energy metabolism in skeletal muscle of rats with postoperative fatigue syndrome and interventional effect of ginsenoside Rb1. Zhongguo Zhong Yao Za Zhi. 36:3489–3493. 2011.(In Chinese).
26	Liu DH, Chen YM, Liu Y, et al: Rb1 protects endothelial cells from hydrogen peroxide-induced cell senescence by modulating redox status. Biol Pharm Bull. 34:1072–1077. 2011. View Article : Google Scholar : PubMed/NCBI
27	Lin ZY, Chen LM, Zhang J, et al: Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels in cultured rat hippocampal neurons. Acta Pharmacol Sin. 33:438–444. 2012. View Article : Google Scholar : PubMed/NCBI
28	Zhu J, Jiang Y, Wu L, Lu T, Xu G and Liu X: Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience. 202:342–351. 2012. View Article : Google Scholar
29	Xia R, Zhao B, Wu Y, et al: Ginsenoside Rb1 preconditioning enhances eNOS expression and attenuates myocardial ischemia/reperfusion injury in diabetic rats. J Biomed Biotechnol. 2011:7679302011. View Article : Google Scholar : PubMed/NCBI
30	Bowes MP, Masliah E, Otero DA, Zivin JA and Saitoh T: Reduction of neurological damage by a peptide segment of the amyloid beta/A4 protein precursor in a rabbit spinal cord ischemia model. Exp Neurol. 129:112–119. 1994. View Article : Google Scholar : PubMed/NCBI
31	Basso DM, Beattie MS, Bresnahan JC, et al: MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J Neurotrauma. 13:343–359. 1996. View Article : Google Scholar : PubMed/NCBI
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
33	Nesic O, Guest JD, Zivadinovic D, et al: Aquaporins in spinal cord injury: the janus face of aquaporin 4. Neuroscience. 168:1019–1035. 2010. View Article : Google Scholar : PubMed/NCBI
34	Bloch O, Papadopoulos MC, Manley GT and Verkman AS: Aquaporin-4 gene deletion in mice increases focal edema associated with staphylococcal brain abscess. J Neurochem. 95:254–262. 2005. View Article : Google Scholar : PubMed/NCBI
35	Li L, Zhang H, Varrin-Doyer M, Zamvil SS and Verkman AS: Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation. FASEB J. 25:1556–1566. 2011. View Article : Google Scholar : PubMed/NCBI